Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OG-6219 in Women With Moderate to Severe Endometriosis-related Pain
NCT05560646Phase 2Completed
- Sponsor
- Organon & Co.
- Start
- Oct 2022
- Primary completion
- May 2025
- Modality
- Small Molecules
- Countries
- 11
01
Overview
A Phase 2 trial of linustedastat in endometriosis, sponsored by Organon & Co.. Started Oct 2022; status: completed.
02
Drugs
linustedastat
03
Conditions
endometriosis
Beyond the preview
Go deeper on NCT05560646.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05560646.